Switch to
More onapp

Fredun Pharmaceuticals Ltd

FREDUN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹446 cr, stock is ranked 1,355
High RiskStock is 3.14x as volatile as Nifty
1,029.0055.75 (-5.14%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹446 cr, stock is ranked 1,355
High RiskStock is 3.14x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
70.43
PB RatioPB Ratio
6.56
Dividend YieldDiv. Yield
0.07%
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Fredun Pharmaceuticals Ltd. is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical formulations. The Company’s products include I V fluids, disposable syringes, infusion sets, surgical gloves and cottons etc.

Financial TrendFinancial statements 

201920202021202297.40113.29135.29226.094.451.902.016.34
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Result 
Announced OnJan 27, 2023

Fredun Pharmaceuticals Ltd - 539730 - Financial Results For Quarter Ended December 31,2022 | Download

Fredun Pharmaceuticals Ltd - 539730 - Financial Results For Quarter Ended December 31,2022 | Download

Board Meeting 
Announced OnJan 27, 2023

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting | Download

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting | Download

Cash Dividend 
Ex. DateSep 16, 2021

Final • Div/Share: ₹ 0.7

See all events